ACM meeting statement, Out of Session Meeting, 13 January 2022

Section A: Pre-market registration applications referred for advice

At this meeting, the committee’s advice was sought on 2 applications under evaluation by the TGA. The applications included:

Further details of the ACM discussion and advice associated with these items may be released within the Australian Public Assessment Reports (AusPARs). Please note that there is a delay from when an application was considered at ACM and the publication of the AusPAR. Browse all AusPARs.

Further information

For further information visit the Advisory Committee on Medicines or contact the ACM Secretary by email: ACM@health.gov.au.